questin has been researched along with butyrolactone i in 1 studies
| Studies (questin) | Trials (questin) | Recent Studies (post-2010) (questin) | Studies (butyrolactone i) | Trials (butyrolactone i) | Recent Studies (post-2010) (butyrolactone i) |
|---|---|---|---|---|---|
| 16 | 0 | 8 | 118 | 0 | 26 |
| Protein | Taxonomy | questin (IC50) | butyrolactone i (IC50) |
|---|---|---|---|
| G1/S-specific cyclin-E2 | Homo sapiens (human) | 1.5 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.6 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 0.6 | |
| G1/S-specific cyclin-E1 | Homo sapiens (human) | 1.5 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JW; Han, HY; Kuo, SC; Liao, WY; Liaw, CC; Lin, LH; Shen, CN; Wu, SH; Yang, YL | 1 |
1 other study(ies) available for questin and butyrolactone i
| Article | Year |
|---|---|
Asperjinone, a nor-neolignan, and terrein, a suppressor of ABCG2-expressing breast cancer cells, from thermophilic Aspergillus terreus.
Topics: Antineoplastic Agents; Aspergillus; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Caspase 7; Cyclopentanes; Drug Screening Assays, Antitumor; Female; Humans; Lignans; Molecular Structure; Neoplasm Proteins; Nuclear Magnetic Resonance, Biomolecular; Proto-Oncogene Proteins c-akt; Taiwan | 2012 |